HUMA
Humacyte, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.60
+0.18%2
Insider buys (3m)
0
Insider sells (3m)
$24.8K
Net value (3m)
-55.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 21, 2026 | Jones Keith Anthony · director | Purchase | 10,000 | $0.69 |
| Aug 19, 2026 | Jones Keith Anthony · director | Purchase | 30,000 | $0.59 |
| Jun 12, 2026 | Wallace Max N. · director | A-Award | 80,000 | $1.08 |
| Jun 12, 2026 | Constantino Michael T. · director | A-Award | 80,000 | $1.08 |
| Jun 12, 2026 | Windham-Bannister Susan Richards · director | A-Award | 80,000 | $1.08 |
| Jun 12, 2026 | Sebelius Kathleen · director | A-Award | 80,000 | $1.08 |
| Jun 12, 2026 | Niklason Laura E · director, officer: President, CEO and Director | A-Award | 80,000 | $1.08 |
| Jun 12, 2026 | Dougan Brady W · director | A-Award | 0 | $1.08 |
| Jun 12, 2026 | Brown Emery N. · director | A-Award | 80,000 | $1.08 |
| Jun 12, 2026 | Bamforth John Philip · director | A-Award | 80,000 | $1.08 |
| Jun 12, 2026 | Seimetz Diane · director | A-Award | 80,000 | $1.08 |
| Jun 12, 2026 | Green Charles Bruce · director | A-Award | 80,000 | $1.08 |
| Jun 12, 2026 | Jones Keith Anthony · director | A-Award | 80,000 | $1.08 |
| May 20, 2026 | Constantino Michael T. · director | Purchase | 11,000 | $0.89 |
| May 20, 2026 | Sebelius Kathleen · director | Purchase | 56,818 | $0.88 |
| May 20, 2026 | Sander Dale A. · officer: CFO and Chief Corp. Dev. Off | Sale | 45,887 | $0.90 |
| May 20, 2026 | Parikh Shamik J · officer: Chief Medical Officer | Sale | 45,887 | $0.90 |
| Nov 17, 2025 | Dougan Brady W · director | A-Award | 311,100 | $1.23 |
| Nov 17, 2025 | Parikh Shamik J · officer: Chief Medical Officer | A-Award | 311,100 | $0.00 |
| Nov 17, 2025 | Sander Dale A. · officer: CFO and Chief Corp. Deve. Off. | A-Award | 311,100 | $0.00 |
| Nov 17, 2025 | Niklason Laura E · director, officer: President, CEO and Director | A-Award | 311,100 | $1.23 |
| Aug 20, 2025 | Dougan Brady W · director | Sale | 549,360 | $1.83 |
| Aug 20, 2025 | Dougan Brady W · director | Sale | 591,685 | $1.58 |
| Aug 20, 2025 | Niklason Laura E · director, officer: President, CEO and Director | Sale | 591,685 | $1.58 |
| Aug 20, 2025 | Niklason Laura E · director, officer: President, CEO and Director | Sale | 1,100,000 | $1.63 |
| Aug 20, 2025 | Niklason Laura E · director, officer: President, CEO and Director | Sale | 549,360 | $1.83 |
| Aug 20, 2025 | Dougan Brady W · director | Sale | 1,100,000 | $1.63 |
| Jun 16, 2025 | Jones Keith Anthony · director | A-Award | 80,000 | $2.41 |
| Jun 16, 2025 | Pope Todd · director | A-Award | 80,000 | $2.41 |
| Jun 16, 2025 | Brown Emery N. · director | A-Award | 80,000 | $2.41 |
Institutional positioning
13F filings over the trailing two quarters
New 73Increased 111Reduced 74Sold out 33
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 12,316,955 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 10,107,679 | Aug 13, 2026 |
| ANTIPODES PARTNERS Ltd | Increased | 10,103,647 | Aug 6, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7,158,162 | May 15, 2026 |
| Alyeska Investment Group, L.P. | New Position | 6,022,925 | Aug 14, 2026 |
| ANTIPODES PARTNERS LTD | Increased | 5,723,750 | May 5, 2026 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | New Position | 5,000,000 | Aug 14, 2026 |
| BlackRock, Inc. | Reduced | 4,839,929 | Aug 7, 2026 |
| GREAT POINT PARTNERS LLC | Unchanged | 3,750,000 | Aug 14, 2026 |
| GREAT POINT PARTNERS LLC | New Position | 3,750,000 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 3,658,108 | May 15, 2026 |
| STATE STREET CORP | Increased | 3,043,929 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 2,890,043 | Aug 14, 2026 |
| UBS Group AG | Increased | 2,843,493 | Aug 13, 2026 |
| UBS GROUP AG | Reduced | 2,782,070 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 21, 2026